mast-group

MAST URI®SYSTEM

MAST has been a manufacturer of antibiotic susceptibility test products since 1957, and continues to be at the forefront of developments in this field. MAST’s original product was the single antibiotic disc, but the expansion of the portfolio has resulted in the most comprehensive range available worldwide.

As a specialist microbiology company, MAST has an extensive range of Dehydrated Culture Media, and selective supplements for the culture, examination, selection, isolation and transport of clinically significant organisms from patient specimens. Not only that, MAST has Identification Products, Antisera, Cryobank and latex agglutination test product ranges as well.

Molecular

MAST has been a manufacturer of antibiotic susceptibility test products since 1957, and continues to be at the forefront of developments in this field. MAST’s original product was the single antibiotic disc, but the expansion of the portfolio has resulted in the most comprehensive range available worldwide.

As a specialist microbiology company, MAST has an extensive range of Dehydrated Culture Media, and selective supplements for the culture, examination, selection, isolation and transport of clinically significant organisms from patient specimens. Not only that, MAST has Identification Products, Antisera, Cryobank and latex agglutination test product ranges as well.

Culture Media

As a specialist Microbiology company, Mast Group Ltd is renowned for its extensive range of dehydrated culture media for in vitro diagnostic use in clinical microbiology, food microbiology, environmental testing and research microbiology.
These products include:
Transport of bacteria and fungi
Isolation and general culture of bacteria and fungi
Presumptive identification of specific bacteria
Antibiotic susceptibility testing
Microbiological assay
Biochemical identification
Environmental sampling
Raw materials
Mast Group Ltd also produce a range of MAST®ID SELECTAVIAL and MAST®ID SELECTATAB supplements for addition to culture media for a variety of purposes including the growth, enrichment, isolation and selection of bacteria.

Pharmaceutical

Mast Group Ltd offers a range of services including mastpharma®development and mastpharma® stability for the evaluation of novel antimicrobial compounds for the pharmaceutical industry.

Clinical trials of antimicrobials require the design of diagnostic services to determine microorganism susceptibility before the compound enters Phase 3 studies.

Antimicrobial susceptibility test discs are proven to be one of the most effective and validated methods to determine bacterial susceptibility in both clinical and veterinary practice and must be commercially available at the launch of the compound to assure full market penetration.

Utilising over 60 years of experience of development and manufacture of antimicrobial test products mastpharma® offers extra confidence in the success of the antimicrobial on final commercialisation.

Mast Group Ltd offers flexible and convenient services to provide pharmaceutical companies with confidence in quality and assist with easy distribution and integration for market evaluations. These include:

  • Continuation of performance studies are available at 3,6,9, and 12 months on first batch manufacture.
  • On compound approval by the FDA and EMA, CLSI and EUCAST disc versions are made available. Antibiotic discs are then launched and supplied as part of the MASTDISCS® stock range.
  • Bespoke labelling is available to customer’s specification fulfilment programmes.
  • Distribution to end users on behalf of the pharmaceutical company.
  • Multiple disc cartridge formats to meet international requirements.

Immunology

Products for investigation of the immune system through identification and detection of immunological markers using Flow Cytometry, ELISA, ELISPOT and agglutination techniques. Additionally, In vitro diagnostic products to screen donated blood and blood fractions, prior to transfusion, for the bacterial and viral causative agents of infectious disease.

  • MASTAFLUOR® Immunofluorescence, MAST®ALEX latex agglutination and MASTAZYME® EIA kits for in vitro diagnosis of autoimmune disease and for the identification of infectious organisms.
  • Detection of cell surface antigens (CD markers) for differentiation and isolation of white blood cells by flow cytometry
  • Quantitation of immunoglobulin subclasses to indicate disease by examination of the immune system
  • Differentiation and isolation of cell populations using cell specific monoclonal antibodies
  • Detection of human cytokine levels by ELISA

Veterinary

Products for diagnostic and research applications in veterinary laboratories to indicate, identify and detect infection and inflammation in a wide range of animal species.

Products encompass a variety of methods including traditional microbiological analysis through to serological techniques for analysis of important biomarkers for numerous chronic inflammatory diseases.

  • MASTDISCS® AST and MASTRING-S® impregnated with antibiotics for susceptibility testing by disc diffusion
  • MASTDISCS® Combi and MASTDISCS® ID Antibiotic resistance detection products for the identification and differentiation of enzymes that hydrolyse beta-lactam antibiotics
  • Serological assays for protein, antibody and antigen detection by MAST®ALEX agglutination kits
  • Serological tests for the quantification of acute phase proteins as indicators of inflammation
Mast Group Ltd.’s expertise in microbiology offers veterinary laboratories the capability to detect many of the most common and relevant bacterial and protozoan veterinary parasites including MRSA and Toxoplasma.

Miscellaneous